Curexo Inc - Asset Resilience Ratio

Latest as of September 2025: 15.27%

Curexo Inc (060280) has an Asset Resilience Ratio of 15.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore total assets of Curexo Inc for the complete picture of this company's asset base.

Liquid Assets

₩15.83 Billion
≈ $10.73 Million USD Cash + Short-term Investments

Total Assets

₩103.65 Billion
≈ $70.24 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how Curexo Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Curexo Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Curexo Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 060280 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩15.83 Billion 15.27%
Total Liquid Assets ₩15.83 Billion 15.27%

Asset Resilience Insights

  • Good Liquidity Position: Curexo Inc maintains a healthy 15.27% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Curexo Inc Industry Peers by Asset Resilience Ratio

Compare Curexo Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Seouleaguer Co. Ltd
KQ:043710
Food & Drug Retailing 0.11%
Gimat Magazacilik Sanayi ve Ticaret AS
IS:GMTAS
Food & Drug Retailing 0.46%

Annual Asset Resilience Ratio for Curexo Inc (2006–2024)

The table below shows the annual Asset Resilience Ratio data for Curexo Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 32.64% ₩33.48 Billion
≈ $22.69 Million
₩102.58 Billion
≈ $69.52 Million
+0.24pp
2023-12-31 32.39% ₩34.78 Billion
≈ $23.57 Million
₩107.37 Billion
≈ $72.76 Million
+10.97pp
2022-12-31 21.42% ₩21.08 Billion
≈ $14.29 Million
₩98.40 Billion
≈ $66.68 Million
+9.07pp
2021-12-31 12.36% ₩7.58 Billion
≈ $5.13 Million
₩61.31 Billion
≈ $41.55 Million
+0.07pp
2020-12-31 12.29% ₩6.01 Billion
≈ $4.07 Million
₩48.88 Billion
≈ $33.12 Million
-2.50pp
2019-12-31 14.79% ₩6.97 Billion
≈ $4.72 Million
₩47.13 Billion
≈ $31.94 Million
-1.65pp
2018-12-31 16.44% ₩12.06 Billion
≈ $8.17 Million
₩73.34 Billion
≈ $49.70 Million
+10.24pp
2017-12-31 6.21% ₩4.69 Billion
≈ $3.18 Million
₩75.55 Billion
≈ $51.20 Million
+1.78pp
2016-12-31 4.42% ₩3.46 Billion
≈ $2.34 Million
₩78.25 Billion
≈ $53.03 Million
+4.32pp
2015-12-31 0.10% ₩60.00 Million
≈ $40.66K
₩58.63 Billion
≈ $39.73 Million
-1.31pp
2014-12-31 1.41% ₩568.30 Million
≈ $385.13K
₩40.34 Billion
≈ $27.33 Million
+1.23pp
2013-12-31 0.18% ₩72.04 Million
≈ $48.82K
₩39.54 Billion
≈ $26.79 Million
-1.14pp
2012-12-31 1.32% ₩680.57 Million
≈ $461.21K
₩51.43 Billion
≈ $34.85 Million
-33.44pp
2011-12-31 34.77% ₩30.62 Billion
≈ $20.75 Million
₩88.07 Billion
≈ $59.68 Million
+26.59pp
2010-12-31 8.17% ₩2.21 Billion
≈ $1.50 Million
₩27.01 Billion
≈ $18.31 Million
+5.24pp
2009-12-31 2.93% ₩913.59 Million
≈ $619.12K
₩31.15 Billion
≈ $21.11 Million
-11.07pp
2008-12-31 14.00% ₩6.68 Billion
≈ $4.52 Million
₩47.70 Billion
≈ $32.32 Million
-3.48pp
2007-12-31 17.48% ₩7.06 Billion
≈ $4.79 Million
₩40.41 Billion
≈ $27.38 Million
-4.88pp
2006-12-31 22.36% ₩8.44 Billion
≈ $5.72 Million
₩37.75 Billion
≈ $25.59 Million
--
pp = percentage points

About Curexo Inc

KQ:060280 Korea Food & Drug Retailing
Market Cap
$277.82 Million
₩409.96 Billion KRW
Market Cap Rank
#15376 Global
#550 in Korea
Share Price
₩12290.00
Change (1 day)
-5.46%
52-Week Range
₩7970.00 - ₩20350.00
All Time High
₩24400.00
About

Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more